Table 2 Follow-up Evaluations
Test and Procedures | 1–4 weeks post SABR treatment and prior to systemic therapy | 3 Months post Randomization | Years 1–2 | Years 3–5 | First progression or study completion (at 5 years post-randomization) whichever is first |
|---|---|---|---|---|---|
Every 3 months | Every 6 months | ||||
History and Physical including assessment of side affects | X | X | |||
CT or MR head, CT chest, abdomen, pelvis | X | X | |||
Bone Scan | X | X | |||
Completion of questionnaires (FACT-G and EQ-5D-5 L) | X | X | |||
Blood Samples for Correlative Studies (i.e studies that are associated with the main study) | X (Arm 2) | X (Arm 1 & 2) | X (Arm 1 & 2) |